Gracell Biotechnologies Inc (GRCL) - News Archive

SAN DIEGO and SUZHOU, China and SHANGHAI, China, Feb. 22, 2024 - Gracell Biotechnologies Inc. (Gracell or the Company, Nasdaq: GRCL) announced the successful completion of its acquisition by AstraZeneca. This historic m...

Gracell Biotechnologies, a global clinical-stage biopharmaceutical company, has announced that its shareholders have voted in favor of a proposed merger with AstraZeneca Treasury and Grey Wolf Merger Sub. This merger, s...

Chinese company Gracell Biotechnologies is poised to make significant strides in the treatment of refractory Systemic Lupus Erythematosus (rSLE). The biotech giant has announced that it has received clearance for IND (I...

:The healthcare industry is constantly evolving, and innovative technologies are paving the way for groundbreaking treatments. In this article, we will discuss the recent developments regarding Third Pole Therapeutics F...

Gracell Biotechnologies, a leading biotechnology company specializing in innovative cellular immunotherapies, recently received FDA clearance for its investigational new drug (IND) application for Phase 1/2 clinical tri...